0001578563-24-000182.txt : 20240325 0001578563-24-000182.hdr.sgml : 20240325 20240325173627 ACCESSION NUMBER: 0001578563-24-000182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240321 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singleton Mark Leonard CENTRAL INDEX KEY: 0001914936 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37844 FILM NUMBER: 24780324 MAIL ADDRESS: STREET 1: C/O BIOVENTUS INC. STREET 2: 4721 EMPEROR BOULEVARD, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bioventus Inc. CENTRAL INDEX KEY: 0001665988 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 810980861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 474-6700 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27703 4 1 wk-form4_1711402578.xml FORM 4 X0508 4 2024-03-21 0 0001665988 Bioventus Inc. BVS 0001914936 Singleton Mark Leonard 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 0 1 0 0 SVP & CFO 0 Class A Common Stock 2024-03-21 4 M 0 18625 A 31206 D Class A Common Stock 2024-03-22 4 S 0 5541 5.3876 D 25665 D Restricted Stock Units 2024-03-21 4 M 0 18625 0 D Class A Common Stock 18625 37250 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2024 pursuant to a standing 10b5-1 instruction. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.36 to $5.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023. /s/ Anthony D'Adamio, Attorney-in-Fact 2024-03-25